Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6568
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
ASBIMA HCT 5MG/160MG/25MG TBL FLM 28 I
0245358 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 30 I
0245359 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 90 I
0245360 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 98 I
0245361 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 28 II
0245362 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 30 II
0245363 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 90 II
0245364 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 98 II
0245365 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 28 III
0245366 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 30 III
0245367 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 90 III
0245368 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/25MG TBL FLM 98 III
0245369 58/ 357/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 28 I
0245370 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 30 I
0245371 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 90 I
0245372 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 98 I
0245373 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 28 II
0245374 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 30 II
0245375 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 90 II
0245376 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/160MG/12,5MG TBL FLM 98 II
0245377 58/ 358/19-C asbimahct.pdf asbimahct.pdf C09DX01 R

‹‹ ‹ 10 20 30 38 39 40 41 42 43 44 45 46 47 48 50 60 70 80 90 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 2. March 2021 at 00:08
Last update of price and payment data: 27. February 2021 at 00:09